Cliff Stocks: Founder and CEO of OncoResponse

Portrait of Cliff Stocks

Cliff Stocks, founder and CEO of OncoResponse speaks with BioBoss host John Simboli. Hear Cliff’s insights about leadership in biopharma and how OncoResponse is working to identify fully human monoclonal antibodies as therapeutics for the treatment of cancer.

Psivant Employees in front of monitor with molecular model.
Psivant Therapeutics

Designing Better Therapeutics, Atom by Atom

Computer chip/molecular design concept animation.

Discovery as a Service

1% Steps for Health Care Reform Policy Brief Authors Portraits
1% Steps for Health Care Reform

Shifting How We Think About Health Care Spending